LEADER 01265cam2-2200385---450 
001 990003689590203316
005 20231213114826.0
010   $a978-0-12-391860-4
035   $a000368959
035   $aUSA01000368959
035   $a(ALEPH)000368959USA01
035   $a000368959
100   $a20120919d2012----km-y0itay50------ba
101   $aeng
102   $aUS
105   $aaf--||||001yy
200 1 $aNanomedicine$ecancer, diabetes and cardiovascular, central nervous system, pulmonary and inflammatory diseases$fedited by Nejat Düzgüne?
210   $aAmsterdam [etc.]$cElsevier$d2012
215   $aLIII, 434 p.$cill.$d24 cm
225 2 $aMethods in enzymology$v508
410  0$1001990002876030203316$12001$aMethods in enzymology$v508
606 0 $aMedicina$xImpiego [delle] Nanotecnologie
676   $a610.28
702  1$aDÜZGÜNES,$bNejat
801  0$aIT$bsalbc$gISBD
912   $a990003689590203316
951   $a572.7 MET 508$b5644 Farm.$c572.7$d00058803
959   $aBK
969   $aFAR
979   $aCHIARA$b90$c20120919$lUSA01$h1430
979   $aCHIARA$b90$c20120919$lUSA01$h1443
979   $aCHIARA$b90$c20120919$lUSA01$h1444
979   $aCHIARA$b90$c20120926$lUSA01$h1455
996   $aNanomedicine$91142294
997   $aUNISA